| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |